Ethics code: IR.MUQ.REC.1397.132
Yusefi H, Parham M, Khadem Haghighian H, Heidari H. Efficacy of Peganum Harmala seed on improving patients with type 2 diabetes - A double blind, randomized, placebo-controlled clinical trial. , Caspian J Intern Med. 2026; 17 (4) :14
URL:
http://caspjim.com/article-1-5018-fa.html
Efficacy of Peganum Harmala seed on improving patients with type 2 diabetes - A double blind, randomized, placebo-controlled clinical trial. ، . 1405; 17 (4) :14
URL: http://caspjim.com/article-1-5018-fa.html
چکیده: (66 مشاهده)
Background: Antioxidant properties of Peganum Harmala (P. harmala) alkaloids were reported. This study was aimed to investigate the antidiabetic, hypolipidemic and hepatoprotective effects of P. harmala in type 2 diabetic patients.
Methods: A total of 80 type 2 diabetes patients aged 40–75 years were allocated to control and test groups. Test group received 1g P. harmala seed, daily for 3 months (as 2 capsules each containing 500mg), and also control group were administered similar appearance capsules containing wheat flour. Blood samples were taken at the beginning and end of the study. Blood glucose (BG), insulin resistance (IR), glycated hemoglobin A1c(HbA1c), lipid profiles, hepatic enzyme, and C-reactive protein (CRP), were measured.
Results: Treatment of diabetic patient with P. harmala seed caused a significant decrease in BG, HbA1c and IR levels as well as remarkable reduce in total cholesterol, triglycerides, low-density lipoprotein, CRP and Alkaline phosphatase (ALP)(P<0.05) level after 3 month. In spite of the elevation of HDL and reduction in serum alanine aminotransferase and aspartate aminotransferase levels in test group, we did not detect a significant difference after 3 months.
Conclusion: This study indicated that P. harmala seed supplementation might have a favorable effect on blood biochemical factors in patients with type 2 diabetes. This is achieved by controlling glycemic status and lipid profile, as well as decreasing serum levels of ALP in these patients compared to the placebo group. However, further investigation is necessary to explore the mechanisms underlying the different alterations of P. harmala seed in diabetes.
نوع مطالعه:
Original Article |
موضوع مقاله:
Physiology دریافت: 1404/9/19 | پذیرش: 1405/7/27 | انتشار: 1405/6/18